Skip to Content

L408 (Darifenacin Hydrobromide Extended-Release 7.5 mg)

Pill with imprint L408 is White, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg. It is supplied by Alembic Pharmaceuticals Inc..

Darifenacin is used in the treatment of urinary frequency; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L408

Darifenacin Hydrobromide Extended-Release

Imprint
L408
Strength
7.5 mg
Color
White
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alembic Pharmaceuticals Inc.
Manufacturer
Alembic Pharmaceutical Limited
National Drug Code (NDC)
62332-0223
Inactive Ingredients
hypromelloses, povidone k30, calcium phosphate dibasic anhydrous, magnesium stearate, titanium dioxide, polyethylene glycol 1500, magnesium silicate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "L408"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.